Interaction of reproductive tract infections with estrogen exposure on breast cancer risk and prognosis
Yunqian Li(Beijing Institute of Petrochemical Technology), Zefang Ren(Sun Yat-sen University), Zhuozhi Liang(Sun Yat-sen University), Ying Lin(Sun Yat-sen University), Qiang Liu(Sun Yat-sen University), XingLi Gan(Sun Yat-sen University), Hengming Ye(Guangdong Medical College), Lu‐Ying Tang(Sun Yat-sen University), Xiaoming Xie(Nanchang University)
Cited by 1
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week
|Nature Communications|2021|261